It’s time for another Who Won the Week prompt. The idea behind Who Won the Week is for you to select who (or what) you think “won” this past week. Your selection can be anyone or anything — politicians, celebrities, athletes, authors, bloggers, your friends or family members, books, movies, TV shows, businesses, organizations, whatever.
I will be posting this prompt on Sunday mornings (my time). If you want to participate, write your own post designating who you think won the week and why you think they deserve your nod. Then link back to this post and tag you post with FWWTW.
I almost didn’t write a Who Won The Week post this week because there are slim pickings. But then I remembered that there was a bit of, shall we say, promising news with respect to the COVID-19 pandemic.
Dr. Anthony Fauci, the nation’s top infectious disease expert, announced this week that a trial of the drug Remdesivir had shown a “clear-cut, significant, positive effect in diminishing the time to recovery” from COVID-19. It was not a knockout punch, according to Dr. Fauci, but it did reduce hospital stays from 15 days to 11 days in the clinical trial.
On Friday, the Food and Drug Administration gave emergency approval for doctors to use Remdesivir, from Gilead Sciences, to treat severely affected patients in hospitals. Those with intensive care units will get the drug first, Gilead said. It will not be available to patients recuperating at home, at least initially.
So for this week, I declare that the drug Remdesivir has won the week. Also, anyone who owns stock in Gilead Sciences, the biopharmaceutical company that manufactures Remdesivir, since it’s likely that, if the drug lives up to its potential, Gilead’s stock will do quite well. Unfortunately for me, I do not own any shares of Gilead. Oh well.
And now it’s your turn, folks. Who (or what) do you think won the week?